Trends and Regional Differences in the Prescription of Prostaglandin Analogs for Glaucoma in England from 2019 to 2024

• by David Grant Robinson, Angela Whitaker

• April 22, 2026

Red-green disease: overreliance on color-coded OCT RNFL analysis in glaucoma diagnosis

• by Venkata S. Jonnakuti, Misha F. Syed, Praveena Gupta

• June 10, 2026

Do Systemic Alpha-2 Agonists Lower Glaucoma Risk?

A large US cohort study found systemic alpha-2 agonist use was associated with a lower hazard of glaucoma-related diagnoses vs. beta-blockers.

• by Andrea Surnit

• July 8, 2026

• 3 min

Minimal effective plate: rethinking plate size in glaucoma drainage devices

• by Giovanni Rubegni, Mostafa Dowidar, Salman Sadiq

• September 16, 2026